Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,320 results for ""INFLIXIMAB""

Your Filters

Publisher : elsevier
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy and Safety of Adalimumab and Infliximab for Noninfectious Uveitis.

  • Authors : Tai F; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.; Mehraban Far P

Subjects: Adalimumab/Adalimumab/Adalimumab/*therapeutic use ; Infliximab/Infliximab/Infliximab/*therapeutic use ; Tumor Necrosis Factor Inhibitors/Tumor Necrosis Factor Inhibitors/Tumor Necrosis Factor Inhibitors/*therapeutic use

  • Source: Ophthalmology [Ophthalmology] 2022 Mar; Vol. 129 (3), pp. 357-359. Date of Electronic Publication: 2021 Oct 08.Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment.

  • Authors : Björnsson HK; Landspitali - The National University Hospital of Iceland, Section of Gastroenterology and Hepatology, Reykjavik, Iceland; Sahlgrenska University Hospital, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Gothenburg, Sweden

Subjects: Adrenal Cortex Hormones/Adrenal Cortex Hormones/Adrenal Cortex Hormones/*pharmacology ; Chemical and Drug Induced Liver Injury/Chemical and Drug Induced Liver Injury/Chemical and Drug Induced Liver Injury/*genetics ; Chemical and Drug Induced Liver Injury/Chemical and Drug Induced Liver Injury/Chemical and Drug Induced Liver Injury/*immunology

  • Source: Journal of hepatology [J Hepatol] 2022 Jan; Vol. 76 (1), pp. 86-92. Date of Electronic Publication: 2021 Sep 03.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Isolation and characterization of charge variants of infliximab biosimilar HS626.

  • Authors : Yuan JJ; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China; Zhejiang Hisun Bioray Biopharmaceutical Co., Ltd., Taizhou, Zhejiang 318000, China.

Subjects: Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/analysis ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/chemistry ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/isolation & purification

  • Source: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2021 Jan 01; Vol. 1162, pp. 122485. Date of Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101139554 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

RETRACTED: Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis.

Subjects: Colitis, Ulcerative/Colitis, Ulcerative/Colitis, Ulcerative/*drug therapy ; Colitis, Ulcerative/Colitis, Ulcerative/Colitis, Ulcerative/*genetics ; Gene Expression/Gene Expression/Gene Expression/*drug effects

  • Source: Translational research : the journal of laboratory and clinical medicine [Transl Res] 2022 Jan; Vol. 239, pp. 35-43. Date of Electronic Publication: 2021 May 07.Publisher: Elsevier Country of Publication: United States NLM ID: 101280339 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Specific single nucleotide polymorphism genotypes and association of an IL-12B polymorphism with secondary failure of infliximab therapy in Japanese psoriasis patients.

  • Authors : Torii K; Department of Geriatric and Environmental Dermatology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.; Morita A

Subjects: Dermatologic Agents/Dermatologic Agents/Dermatologic Agents/*pharmacology ; Drug Resistance/Drug Resistance/Drug Resistance/*genetics ; Infliximab/Infliximab/Infliximab/*pharmacology

  • Source: Journal of dermatological science [J Dermatol Sci] 2020 Aug; Vol. 99 (2), pp. 135-136. Date of Electronic Publication: 2020 May 31.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9011485 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The Tricky Trachea: Tracheitis and Mediastinitis Treated With Infliximab and Steroids in a Patient With Ulcerative Colitis.

  • Authors : Chakraborty D; Department of Medicine, Division of Respirology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. Electronic address: .; Shepherd J

Subjects: Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/diagnosis ; Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/physiopathology ; Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/therapy

  • Source: Chest [Chest] 2021 Sep; Vol. 160 (3), pp. e255-e258.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Implementation of infliximab standardized doses after pharmacokinetic modelization in a cohort of patients with Crohn's disease.

  • Authors : Poullenot F; CHU De Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie, CMC Magellan, Bordeaux, Pessac, France. Electronic address: .; Ollivier J

Subjects: Drug Costs* ; Drug Dosage Calculations*; Crohn Disease/Crohn Disease/Crohn Disease/*drug therapy

  • Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2020 Apr; Vol. 52 (4), pp.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Patients' perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study.

  • Authors : Petitdidier N; Department of Gastroenterology, Henri Mondor Hospital, APHP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.; Tannoury J

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/administration & dosage ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/adverse effects ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/administration & dosage

  • Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2019 Dec; Vol. 51 (12), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

B-cell activating factor (BAFF) expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment.

  • Authors : Andreou NP; Laboratory of Biology, Medical School, National and Kapodistrian University of Athens, Michalakopoulou 176, 11527 Athens, Greece.; Legaki E

Subjects: B-Cell Activating Factor/B-Cell Activating Factor/B-Cell Activating Factor/*drug effects ; Crohn Disease/Crohn Disease/Crohn Disease/*drug therapy ; Infliximab/Infliximab/Infliximab/*therapeutic use

  • Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2021 May; Vol. 53 (5), pp.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Report

Reactivation of Plasmodium infection during a treatment with infliximab: A case report.

  • Authors : Haeseleer C; Department of Hematology, Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium; Université Libre de Bruxelles, Brussels, Belgium. Electronic address: .

Subjects: Infliximab/Infliximab/Infliximab/*adverse effects ; Malaria, Falciparum/Malaria, Falciparum/Malaria, Falciparum/*etiology; Adult

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2020 Feb; Vol. 91, pp. 101-103. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,320 results for ""INFLIXIMAB""